For the Inventor, By the Inventor

Enter inventor name

Lyne Gagnon

USPTO Granted Patents = 28 (Patent Applications = 9)

CIPO Patents = 14 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 19)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 65(Granted Patents)

Location History:

Québec, CA (2014 - 2015)
Quebec, CA (2010 - 2017)
Laval, CA (1999 - 2023)

Company Filing History:

Prometic Biosciences Inc.

Prometic Pharma Smt Limited

Liminal Biosciences Limited

Biochem Pharma Inc.

Prometic Biotherapeutics, Inc.

Years Active: 1999-2023

Loading Chart...

Loading Chart...

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11826404 - Plasminogen treatment of conditions associated with PAI-1 overexpression (2023-11-28),

2. 11524930 - Substituted aromatic compounds and related method for the treatment of fibrosis (2022-12-13),

3. 11267779 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2022-03-08),

4. 11185521 - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis (2021-11-30),

5. 10925846 - Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis (2021-02-23),

6. 10869849 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2020-12-22),

7. 10815183 - Substituted aromatic compounds and pharmaceutical uses thereof (2020-10-27),

8. 10550066 - Substituted aromatic compounds and related method for the treatment of fibrosis (2020-02-04),

9. 10450258 - Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2019-10-22),

10. 10391073 - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration (2019-08-27),

11. 10105331 - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes (2018-10-23),

12. 10023518 - Substituted aromatic compounds and related method for the treatment of fibrosis (2018-07-17),

13. 9938221 - Substituted aromatic compounds and pharmaceutical uses thereof (2018-04-10),

14. 9884802 - Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis (2018-02-06),

15. 9682054 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis (2017-06-20),

Title: The Innovative Journey of Lyne Gagnon

Introduction: Lyne Gagnon, a talented inventor hailing from Laval, Canada, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Lyne Gagnon's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance security measures and a wearable health monitoring system that tracks vital signs in real-time.

Career Highlights: Throughout her illustrious career, Lyne Gagnon has been recognized for her innovative spirit and dedication to creating cutting-edge solutions. Her inventions have not only improved the lives of many but have also set new standards in the industry.

Collaborations: Lyne Gagnon has collaborated with leading tech companies and research institutions to further develop her inventions and bring them to the market. Her ability to work seamlessly with teams of experts has been instrumental in the success of her projects.

Conclusion: In conclusion, Lyne Gagnon's passion for innovation and her relentless pursuit of excellence have established her as a prominent figure in the world of inventors. Her remarkable achievements continue to inspire aspiring inventors and pave the way for future technological advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…